Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort
- PMID: 17909076
- PMCID: PMC2200853
- DOI: 10.1182/blood-2007-07-100719
Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort
Abstract
The Cooperative Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very young children with sickle cell disease (SCD) increased the risk of later adverse outcomes, including death, stroke, frequent pain, and recurrent acute chest syndrome. This model has not been validated in other cohorts. We evaluated its performance in the Dallas Newborn Cohort, a newborn inception cohort of children with SCD. We studied 168 children (55% male, 97% sickle cell anemia) with a mean follow-up of 7.1 years who provided 1188 patient-years of observation. Of the 23 (13.7%) subjects who experienced adverse events, 2 (1.2%) died, 14 (8.3%) had a stroke, 4 (2.4%) had frequent pain, and 3 (1.8%) had recurrent acute chest syndrome. No relationship existed between early clinical predictors and later adverse outcomes, with the possible exception of leukocyte count. Most subjects who experienced adverse events were predicted to be at low risk for those events. No subject who was predicted to be at high risk actually experienced an adverse outcome. The sensitivity of the model did not rise above 20% until specificity fell below 60%. We suggest that this model not be used as a criterion to initiate early interventions for SCD.
Figures

Similar articles
-
Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.Blood. 2007 Jan 1;109(1):40-5. doi: 10.1182/blood-2006-02-005082. Epub 2006 Aug 29. Blood. 2007. PMID: 16940426 Free PMC article.
-
Prediction of adverse outcomes in children with sickle cell disease.N Engl J Med. 2000 Jan 13;342(2):83-9. doi: 10.1056/NEJM200001133420203. N Engl J Med. 2000. PMID: 10631276
-
Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99).Paediatr Perinat Epidemiol. 2006 Jan;20(1):59-66. doi: 10.1111/j.1365-3016.2006.00692.x. Paediatr Perinat Epidemiol. 2006. PMID: 16420342
-
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.Blood. 1995 Jul 15;86(2):776-83. Blood. 1995. PMID: 7606007 Review.
-
Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment.Am Fam Physician. 2000 Sep 15;62(6):1309-14. Am Fam Physician. 2000. PMID: 11011859 Review.
Cited by
-
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia.PLoS One. 2016 Oct 6;11(10):e0164364. doi: 10.1371/journal.pone.0164364. eCollection 2016. PLoS One. 2016. PMID: 27711207 Free PMC article.
-
Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.BMC Pediatr. 2019 Oct 25;19(1):381. doi: 10.1186/s12887-019-1758-2. BMC Pediatr. 2019. PMID: 31651270 Free PMC article.
-
Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease.Anemia. 2012;2012:156598. doi: 10.1155/2012/156598. Epub 2012 May 23. Anemia. 2012. PMID: 22675614 Free PMC article.
-
Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.PLoS One. 2018 Mar 1;13(3):e0192710. doi: 10.1371/journal.pone.0192710. eCollection 2018. PLoS One. 2018. PMID: 29494636 Free PMC article.
-
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25. Semin Hematol. 2018. PMID: 29958564 Free PMC article. Review.
References
-
- Quinn CT, Miller ST. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematol Oncol Clin North Am. 2004;18:1339–1354. - PubMed
-
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11. - PubMed
-
- Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004;104:336–339. - PubMed
-
- Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83–89. - PubMed